These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3017398

  • 1. Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.
    Nauta MM, Boven E, Schlüper HM, Erkelens CA, Pinedo HM.
    Br J Cancer; 1986 Aug; 54(2):331-5. PubMed ID: 3017398
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of human ovarian cancer lines with a panel of monoclonal antibodies (MoAbs).
    Molthoff CF, Boven E, Calame JJ, van Beek PJ, Pinedo HM.
    Strahlenther Onkol; 1989 Jul; 165(7):494-5. PubMed ID: 2546266
    [No Abstract] [Full Text] [Related]

  • 3. Cellular immunologic responsiveness to extracts of ovarian epithelial tumors.
    Melnick H, Barber HR.
    Gynecol Oncol; 1975 Mar; 3(1):77-86. PubMed ID: 168133
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y, Iwabuchi H, Sakunaga H, Sakamoto M, Okabe K, Sato H, Asano G.
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitation of immunoglobulins in the effusions of human ovarian epithelial neoplasms.
    Kutteh WH, Gall SA, Doellgast GJ, Allitto BA, Dawson JR.
    Am J Obstet Gynecol; 1984 Sep 01; 150(1):65-9. PubMed ID: 6476028
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Quantitation of secretory component levels in cyst fluids, ascitic fluids, and sera from ovarian adenocarcinoma patients.
    Klein JL, Gall SA, Dawson JR.
    J Natl Cancer Inst; 1978 Jul 01; 61(1):57-60. PubMed ID: 209204
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma].
    Sakayori M, Nozawa S, Udagawa Y, Chin K, Lee SG, Sakuma T, Iizuka R, Wada Y, Yoshida S, Takeda Y.
    Hum Cell; 1990 Mar 01; 3(1):52-6. PubMed ID: 2083224
    [Abstract] [Full Text] [Related]

  • 20. [Antitumor effect of PSK and its combined effect with CDDP on ovarian serous adenocarcinoma-bearing nude mice].
    Ishii K, Kita T, Hirata J, Tode T, Kikuchi Y, Nagata I.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Apr 01; 45(4):333-9. PubMed ID: 8509669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.